In vitro gain-of-function and loss-of-function studies of miR-21 confirm that it protects against ischemia-induced cardiomyocytes apoptosis by inhibiting programmed cell death protein 4 (PDCD4) and activator protein 1 (AP-1). This evidence concerns the gene PDCD4 and ischemia.